Philip Lao

Philip Lao has extensive experience in business development and licensing roles in the biotechnology and pharmaceutical industries. Philip currently holds the position of Vice President - Business Development at Adverum Biotechnologies. Prior to this, they served as Vice President - Business Development & Licensing at Axcella. Philip's previous roles include Executive Director - Business Development at Alaunos Therapeutics, Senior Director - Global Business Development at Takeda Pharmaceuticals, and Director - Business Development Evaluation at Pfizer. Philip also has experience in corporate mergers and acquisitions as an Associate Project Manager at Novartis and in healthcare investment banking as an Analyst at Deutsche Bank.

Philip Lao attended the University of Chicago, where they earned a Bachelor of Arts degree in Economics. Philip then pursued further education at the London School of Economics and Political Science, completing a General Course. Finally, they attended the University of Chicago Booth School of Business to obtain their Master of Business Administration (MBA) degree in Finance.